Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation

Congenital Heart Disease

Volumn 7, Issue 1, 2012, Pages 24-30

  Turner, Zachary ^a   Lanford, Lizabeth ^a   Webber, Steven ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Budesonide; Fontan; PLE

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BUDESONIDE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; OCTREOTIDE; SILDENAFIL; STEROID; WARFARIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; FONTAN PROCEDURE; GASTROINTESTINAL HEMORRHAGE; HEART TRANSPLANTATION; HUMAN; MALE; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; RETROSPECTIVE STUDY; SYMPTOM;

ADMINISTRATION, ORAL; ALBUMINS; BIOLOGICAL MARKERS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; FEMALE; FONTAN PROCEDURE; GLUCOCORTICOIDS; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; INFANT; INFUSIONS, PARENTERAL; MALE; PALLIATIVE CARE; PENNSYLVANIA; PROTEIN-LOSING ENTEROPATHIES; RETROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856360216     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2011.00593.x     Document Type: Article

References (23)

1. Braamskamp MJ, Dolman KM, Tabbers MM. Clinical practice: protein-losing enteropathy in children. Eur J Pediatr. 2010;169:1179-1185.
2. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis. 2007;2:288-300.
3. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewilig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study. J Thorac Cardiovasc Surg. 1998;115:1063-1073.
4. Feldt RH, Driscoll DJ, Offord KP, etal. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg. 1996;112:672-680.
5. Zellers TM, Brown K. Protein losing enteropathy after the modified Fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement. Pediatr Cardiol. 1996;17:115-117.
6. Ghanayem NS, Berger S, Tweddell JS. Medical management of the failing Fontan. Pediatr Cardiol. 2007;28:465-471.
7. Silvilairat S, Cabalka AK, Cetta F, Grogan M, Hagler DJ, O'Leary PW. Protein-losing enteropathy after the Fontan operation: associations and predictors of clinical outcome. Congenit Heart Dis. 2008;3:262-268.
8. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after Fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg. 2006;82:695-700.
9. Rychik J, Wernovsky G. Complications after the Fontan operation: protein-losing enteropathy and thromboembolism. In: Rychik J, Wernovsky G, eds. Hypoplastic Left Heart Syndrome. Boston, Ma: Kluwer; 2003: 347-360.
10. Rychik J, Gui-Yang S. Relation of mesenteric vascular resistance after Fontan operation and protein-losing enteropathy. Am J Cardiol. 2002;90:672-674.
11. Vyas H, Driscoll DJ, Cabalka AK, Cetta F, Haggler DJ. Results of transcatheter Fontan fenestration to treat protein-losing enteropathy. Catheter Cardiovasc Interv. 2007;69:584-589.
12. Uzun O, Wong JK, Bhole V, Stumper O. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg. 2006;82:e39-e40.
13. Kelly AM, Feldt RH, Driscoll DJ, Danielson DK. Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease. Mayo Clin Proc. 1998;73:777-779.
14. Bernstein D, Naftel D, Chin C, etal. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273-280.
15. Hofer KN. Oral budesonide in the management of Crohn's disease. Ann Pharmacother. 2003;37:1457-1464.
16. Madisch A, Heymer P, Voss C, etal. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis. 2005;20:312-316.
17. Thacker D, Patel A, Dodds K, Goldberg D, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg. 2010;89:387-342.
18. Weinstein S, Chan D. Extracardiac Fontan conversion, cryoablation, and pacemaker placement for patients with a failed Fontan. Semin Thorac Cardiovasc Surg. 2005;17:170-178.
19. Heinemann MK, Gass M, Breuer J, Ziemer G. DDD pacemaker implantation after Fontan-type operations. Pacing Clin Electrophysiol. 2003;26:492-495.
20. Rychik J. Management of protein-losing enteropathy after the Fontan procedure. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1998;1:15-22.
21. Thierren J, Webb GD, Gatzoulis MA. Reversal of protein losing enteropathy with prednisone in adults with modified Fontan operations: long term palliation or bridge to cardiac transplantation? Heart. 1999;82:241-243.
22. Rothman A, Snyder J. Protein-losing enteropathy following the Fontan operation: resolution with prednisone therapy. Am Heart J. 1991;121:618-619.
23. EntocortEC (AztraZeneca) leaflet. Available at: Accessed June 28, 2009.